STAAR Surgical Company
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +172.0% | +347.5% | +102.0% | -18.8% | +109.8% | -18.8% | -59.1% | +7.7% | -317.7% | |
| – | -2.4% | +20.4% | +16.0% | -26.5% | +50.1% | -16.3% | +17.7% | +23.8% | +13.6% | +34.5% | +20.7% | |
| – | -29.1% | +159.0% | -63.1% | +113.9% | +56.0% | +15.2% | +20.2% | +39.5% | +15.4% | +15.7% | +12.4% | |
| – | +2.9% | +84.9% | -28.6% | +76.3% | -6.8% | +57.3% | +29.6% | +16.9% | – | – | – | |
| – | – | – | -283.4% | – | – | – | – | – | – | – | – | |
| – | -49.6% | +56.9% | -67.4% | +114.6% | +353.4% | -17.4% | +62.4% | +32.7% | +0.4% | +28.6% | -75.1% | |
| – | -49.6% | +56.9% | -67.4% | +114.6% | +353.4% | -17.4% | +62.4% | +1,046.0% | – | -179.6% | – | |
| – | – | – | -0.3% | +30.9% | – | – | – | – | – | – | – | |
| – | +64.5% | -112.3% | -61.7% | -76.9% | – | +496.5% | -100.0% | – | – | -28.2% | +329.3% | |
| – | -20.2% | – | -215.9% | +104.2% | -24.0% | -74.5% | +219.4% | -92.3% | +27.8% | +2.5% | -74.5% | |
| – | +80.8% | -35.5% | -17.5% | +2,962.7% | -99.8% | +13,034.9% | -9.1% | -53.4% | -10.6% | -22.8% | -179.6% | |
| – | – | +53.5% | +657.6% | +1,787.2% | -81.3% | +103.4% | +45.5% | -339.6% | – | -140.3% | – | |
| – | – | – | – | +482.3% | +48.4% | -19.7% | +141.6% | -41.9% | -120.4% | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.